Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.

Blauvelt Andrew, de Bruin-Weller Marjolein, Gooderham Melinda, Cather Jennifer C, Weisman Jamie, Pariser David, Simpson Eric L, Papp Kim A, Hong H Chih-Ho, Rubel Diana, Foley Peter, Prens Errol, Griffiths Christopher E M, Etoh Takafumi, Pinto Pedro Herranz, Pujol Ramon M, Szepietowski Jacek C, Ettler Karel, Kemény Lajos, Zhu Xiaoping, Akinlade Bolanle, Hultsch Thomas, Mastey Vera, Gadkari Abhijit, Eckert Laurent, Amin Nikhil, Graham Neil M H, Pirozzi Gianluca, Stahl Neil, Yancopoulos George D, Shumel Brad: Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
LANCET, 389 (10086). pp. 2287-2303. ISSN 0140-6736 (2017)

[img] Text
3230565_Blauvelt.pdf - Published Version
Korlátozott. Repository staff only

Download (561kB) | Request a copy
Item Type: Article
Journal or Publication Title: LANCET
Date: 2017
Volume: 389
Number: 10086
Page Range: pp. 2287-2303
ISSN: 0140-6736
Publisher: The Lancet Publishing Group
Faculty: Általános Orvostudományi Kar
Institution: Szegedi Tudományegyetem
SWORD language: Angol
Identification Number: 3230565
DOI id: https://doi.org/10.1016/S0140-6736(17)31191-1
Date Deposited: 2017. Oct. 19. 16:00
Last Modified: 2017. Oct. 19. 16:00
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11568

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year